在患有异常性肺纤维化症的患者中,用Nintedanib进行基于患者个人资料的管理
Vinod K Viswanathan1, Aloke G Ghoshal2, Anant Mohan3
1Institute of Thoracic Medicine, Madras Medical College, Chennai, India.
丁丁达尼布是治疗异常性肺纤维化 (IPF) 的有效治疗方法,减缓肺功能下降. 管理腹等副作用是保持治疗坚持和IPF患者的积极结果的关键.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 异形性肺纤维化 (IPF) 是一种严重的,渐进的间歇性肺病,原因不明.
- 丁丁达尼布是IPF的药理干预,在临床试验中显示出有效性.
- 糖尿病和高血压等并发症可以使IPF的结果恶化,并降低治疗坚持.
研究的目的:
- 评估宁泰达尼布在治疗IPF中的疗效和安全性.
- 了解宁泰达尼布在IPF和并发症患者中的作用.
- 概述管理宁特丹尼布不良影响的策略.
主要方法:
- 在IPF中对任天达尼布进行多项随机的安慰剂受控试验的审查.
- 对现实世界证据研究的分析,这些研究支持了任天堂的使用.
- 审查宁泰达尼布的安全性,重点是胃肠道的不良影响.
主要成果:
- 丁丁达尼布减缓肺功能下降,并为IPF患者提供临床益处.
- 现实世界的数据证实了宁泰达尼布作为一种高效且耐受良好的治疗选择.
- 胃肠道不良反应,特别是腹,是最常见的副作用.
结论:
- 丁丁达尼布是稳定IPF进展的有价值的治疗选择.
- 有效的副作用管理,包括剂量调整和症状治疗,对于治疗的延续至关重要.
- 监测肝酶和积极管理不良事件可以防止永久性停止治疗.
更多相关视频
06:03Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Pulmonary Embolism III: Nursing Management
Myocarditis IV: Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
